Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald B Postuma

Showing results (211-220 of 284) with videos related to

Pageof 29
Sort By:
Journal of Neurology|September 26, 2024
Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severityMaria Livia Fantini, Ronald B Postuma, Monica Puligheddu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 11, 2019
Canadian guideline for Parkinson diseaseDavid Grimes, Megan Fitzpatrick, Joyce Gordon, et al.
Nature Medicine|October 8, 2024
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trialGennaro Pagano, Annabelle Monnet, Adriana Reyes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
The Lancet. Neurology|June 16, 2016
The new definition and diagnostic criteria of Parkinson's diseaseRonald B Postuma, Daniela Berg, Charles H Adler, et al.
Neurology|September 16, 2025
Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI StudyViolette Ayral, Alexandre Pastor-Bernier, Véronique Daneault, et al.
Parkinsonism & Related Disorders|January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline dataTania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
Brain : a Journal of Neurology|May 20, 2022
Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expressionShady Rahayel, Christina Tremblay, Andrew Vo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
C9orf72 repeat expansions in rapid eye movement sleep behaviour disorderHussein Daoud, Ronald B Postuma, Cynthia V Bourassa, et al.
Brain : a Journal of Neurology|February 24, 2023
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathiesShady Rahayel, Christina Tremblay, Andrew Vo, et al.
Pageof 29

Showing results (211-220 of 284) with videos related to

Sort By:
Pageof 29
Journal of Neurology|September 26, 2024
Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severityMaria Livia Fantini, Ronald B Postuma, Monica Puligheddu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 11, 2019
Canadian guideline for Parkinson diseaseDavid Grimes, Megan Fitzpatrick, Joyce Gordon, et al.
Nature Medicine|October 8, 2024
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trialGennaro Pagano, Annabelle Monnet, Adriana Reyes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
The Lancet. Neurology|June 16, 2016
The new definition and diagnostic criteria of Parkinson's diseaseRonald B Postuma, Daniela Berg, Charles H Adler, et al.
Neurology|September 16, 2025
Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI StudyViolette Ayral, Alexandre Pastor-Bernier, Véronique Daneault, et al.
Parkinsonism & Related Disorders|January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline dataTania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
Brain : a Journal of Neurology|May 20, 2022
Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expressionShady Rahayel, Christina Tremblay, Andrew Vo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
C9orf72 repeat expansions in rapid eye movement sleep behaviour disorderHussein Daoud, Ronald B Postuma, Cynthia V Bourassa, et al.
Brain : a Journal of Neurology|February 24, 2023
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathiesShady Rahayel, Christina Tremblay, Andrew Vo, et al.
Pageof 29